International Conference on Occupational Radiation Protection: Strengthening Radiation Protection of Workers – Twenty Years of Progress and the Way Forward

Managing Occupational Exposures During I-131 MIBG Therapy

Not scheduled

1h 30m

Geneva

Poster 4. Occupational radiation protection in medicine Session 8. Occupational radiation protection in medicine

Speaker

Mr William Lorenzen (Boston Children's Hospital / Harvard Medical School)

Description

The use of I-131 MIBG for the therapeutic treatment of relapse neuroblastoma in pediatric patients has been used for over 15 years. This treatment involves the administration of I-131 MIBG at doses up to 0.67 GBq/Kg. The therapy requires careful management of not only the patient but the various hospital staff and caregivers involved in patient treatment and support. The primary supporting care team includes Nuclear Medicine, Nursing, Physicians, Caregivers, and Radiation Safety. The various radiation safety policies and procedures as well as operational best practices that have been established over many years of treating these patients will be discussed.

Presentation materials

IAEA-CN-300-P-S8-69.pdf